EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proenkephalin A 119-159 in Kidney Transplantation: A Novel Biomarker for Superior Tracking of Graft Function Trajectories

Louise Benning, Marvin Reineke, Camila Eleuterio Rodrigues, Florian Kälble, Claudius Speer, Claudia Sommerer, Christoph F Mahler, Felix C F Schmitt, Markus Mieth, Martin Zeier, Christoph Michalski, Arianeb Mehrabi und 8 weitere

Transplant International · 2025

DOI: 10.3389/ti.2025.14366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant International, 2025. Verfasst von Louise Benning und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany. Hauptthemen laut MEDLINE: Kidney Transplantation, Enkephalins, Protein Precursors, Delayed Graft Function. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate assessment of graft function trajectories after kidney transplantation is essential for optimizing patient management. Slow graft function (SGF) and delayed graft function (DGF) are associated with impaired recovery, yet current diagnostic tools lack granularity for timely risk stratification. Proenkephalin A 119-159 (penKid) may improve graft function assessment, enhancing risk stratification for SGF, DGF, and associated outcomes. This prospective study evaluated 159 kidney transplant recipients at Heidelberg University Hospital to compare plasma penKid levels with current risk-indicators for poor (functional) graft trajectories. Validation was conducted using an independent transplant cohort from Sydney. Clinical relevance of biomarker-indicated changes in graft function was assessed using multivariable regression models and AUROC analyses. From day one post-transplant, penKid outperformed serum creatinine (SCr) in identifying functional trajectories associated with DGF (AUROC penKid: 0.87 vs. SCr: 0.56) and differentiated SGF from DGF (AUROC penKid: 0.79 vs. SCr: 0.33) up to eight days earlier. PenKid further demonstrated superior granularity in assessing DGF severity and 30-day outcomes. After adjustment for common risk factors, penKid remained the strongest risk stratifier for all tested outcomes. PenKid is a superior biomarker for earlier assessment of graft function trajectories, offering potential to enhance personalized care and clinical trial designs in kidney transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationEnkephalinsProtein PrecursorsDelayed Graft FunctionHumansMaleFemaleBiomarkersMiddle AgedProspective StudiesAdultCreatinineAgedRisk AssessmentRisk Factors

Stichwörter der Autor:innen

delayed graft functiongraft function trajectorykidney graft recoveryproenkephalin Arisk stratificationslow graft functionstudy enrichment

Substanzen

BiomarkersEnkephalinsProtein PrecursorsproenkephalinCreatinine

Autor:innen und Institutionen

  • Department of Nephrology, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.
  • Department of Nephrology, Prince of Wales Hospital, Sydney, NSW, Australia.
  • Department of Nephrology, Hospital das Clínicas - University of São Paulo School of Medicine, São Paulo, Brazil.
  • Department of Anaesthesiology, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.
  • Department of General, Visceral, and Transplantation Surgery, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.
  • SphingoTec GmbH, Berlin, Germany.

Zitieren

APA

Benning, L., Reineke, M., Rodrigues, C. E., Kälble, F., Speer, C., Sommerer, C., Mahler, C. F., Schmitt, F. C. F., Mieth, M., Zeier, M., Michalski, C., Mehrabi, A., Hartmann, O., Zorn, M., Anker, S. C., Czock, D., Weigand, M. A., Endre, Z., Morath, C., & Nusshag, C. (2025). Proenkephalin A 119-159 in Kidney Transplantation: A Novel Biomarker for Superior Tracking of Graft Function Trajectories. Transplant International. https://doi.org/10.3389/ti.2025.14366

Vancouver

Benning L, Reineke M, Rodrigues CE, Kälble F, Speer C, Sommerer C, et al. Proenkephalin A 119-159 in Kidney Transplantation: A Novel Biomarker for Superior Tracking of Graft Function Trajectories. Transplant International. 2025. doi:10.3389/ti.2025.14366

BibTeX
@article{Benning2025,
  author = {Benning, Louise and Reineke, Marvin and Rodrigues, Camila Eleuterio and Kälble, Florian and Speer, Claudius and Sommerer, Claudia and Mahler, Christoph F and Schmitt, Felix C F and Mieth, Markus and Zeier, Martin and Michalski, Christoph and Mehrabi, Arianeb and Hartmann, Oliver and Zorn, Markus and Anker, Sophie C and Czock, David and Weigand, Markus A and Endre, Zoltan and Morath, Christian and Nusshag, Christian},
  title = {Proenkephalin A 119-159 in Kidney Transplantation: A Novel Biomarker for Superior Tracking of Graft Function Trajectories},
  journal = {Transplant International},
  year = {2025},
  doi = {10.3389/ti.2025.14366}
}
Kostenlos starten →